000 01647 a2200433 4500
005 20250514074005.0
264 0 _c20040302
008 200403s 0 0 eng d
022 _a0889-2229
024 7 _a10.1089/088922203766774487
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCoplan, Paul M
245 0 0 _aIncidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors.
_h[electronic resource]
260 _bAIDS research and human retroviruses
_cJun 2003
300 _a449-55 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAnti-HIV Agents
_xtherapeutic use
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHIV Protease Inhibitors
_xadverse effects
650 0 4 _aHIV-1
_xdrug effects
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aMale
650 0 4 _aMyocardial Infarction
_xepidemiology
650 0 4 _aReverse Transcriptase Inhibitors
_xtherapeutic use
700 1 _aNikas, Alexander
700 1 _aJapour, Anthony
700 1 _aCormier, Karen
700 1 _aMaradit-Kremers, Hilal
700 1 _aLewis, Ron
700 1 _aXu, Yi
700 1 _aDiNubile, Mark J
773 0 _tAIDS research and human retroviruses
_gvol. 19
_gno. 6
_gp. 449-55
856 4 0 _uhttps://doi.org/10.1089/088922203766774487
_zAvailable from publisher's website
999 _c12659679
_d12659679